Key result
Routine baseline echocardiograms before anthracyclines in standard-risk B-lymphoblastic leukemia lack utility and can be safely omitted.
Why the study?
The utility of a routine baseline echocardiogram prior to anthracycline administration in patients with SR B-ALL was not clear.
Does a routine baseline echocardiogram provide clinical utility in children with SR B-ALL prior to anthracycline administration?
Does a routine baseline echocardiogram provide clinical utility in children with SR B-ALL prior to anthracycline administration?
Routine baseline echocardiograms prior to anthracycline administration in children with standard risk B-ALL lack clear utility and can be safely omitted to reduce costs and discomfort.
May warrant omitting routine baseline echocardiography in standard-risk B-ALL; challenges current practice to reduce costs and discomfort.
A routine baseline echocardiogram in patients with SR B-ALL prior to anthracycline administration is without clear utility. Based on these results, a change in practice was implemented in our institution to discontinue routine pre-anthracycline echocardiograms for this population. Omitting this low-value test may reduce unnecessary discomfort in children, family worry, and health-care-related costs.
No takes yet. Share an insight, caveat, or question.
Alrajhi et al. (2026) studied this question. Routine baseline echocardiograms prior to anthracycline administration in patients with standard-risk B-lymphoblastic leukemia lack clear utility and can be safely omitted.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: